We’ve previously posted (here, here, and here) about Gunvalson v. PTC, in which a federal trial court ordered a drug company to provide an experimental drug to a patient (outside of the context of a clinical trial).

Others on the web have also covered that story.

Because we’re now both involved in the appeal, we’re no longer saying anything substantive about the case. But, for the benefit of those who are watching Gunvalson, here are links to the two friend of the court (or “amicus curiae“) briefs filed in support of the company’s position.

First, here’s the brief of a family of a child suffering from Duchenne Muscular Dystrophy.

Second, here’s the brief of the Parent Project for Muscular Dystropy Research .